Comparison of lenvatinib plus pembrolizumab versus firstline systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: A real-world retrospective study

被引：0
|
作者：
Yang, Z. [1 ]
Hu, D. [1 ]
Chen, M. [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Liver Surg, Canc Ctr, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.449
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
306P
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [31] Induction chemotherapy with sequential nimotuzumab plus concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma: A retrospective real-world study
    Jiang, Danxian
    Cao, Jinxin
    Guo, Linying
    Chen, Yonghua
    Yuan, Ge
    Huang, Jing
    MEDICINE, 2023, 102 (04) : E32732
  • [32] Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study
    Narita, Takuma
    Hatakeyama, Shingo
    Numakura, Kazuyuki
    Kobayashi, Mizuki
    Muto, Yumina
    Saito, Mitsuru
    Narita, Shintaro
    Tanaka, Toshikazu
    Noro, Daisuke
    Tokui, Noriko
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 899 - 905
  • [33] HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study
    Chang, Xu
    Li, Xinge
    Sun, Peng
    Li, Zhenfeng
    Sun, Pengfei
    Ning, Shangkun
    BMC CANCER, 2024, 24 (01)
  • [34] Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study
    Xu, Qian
    Yi, Dan
    Jia, Caiyan
    Kong, Fanming
    Jia, Yingjie
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis
    Leyh, Catherine
    Ehmer, Ursula
    Roessler, Daniel
    Philipp, Alexander B.
    Reiter, Florian P.
    Jeliazkova, Petia
    Jochheim, Leonie S.
    Jeschke, Matthias
    Hammig, Janina
    Ludwig, Johannes M.
    Theysohn, Jens M.
    Geier, Andreas
    Lange, Christian M.
    CANCERS, 2022, 14 (08)
  • [36] A retrospective real-world study of nimotuzumab combined with chemotherapy for advanced pancreatic cancer
    Wu, Yinying
    Dong, Xuyuan
    Li, EnXiao
    Fan, Yangwei
    Dong, Danfeng
    Shi, Yu
    Wang, Meichen
    Yang, Nan
    Ou, Fengyun
    Wang, Jia
    Yang, Yuqian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab
    Pawsey, A.
    Mahalingam, P.
    Senthivel, N.
    Ramessur, A.
    Turnbull, E.
    Usman, S.
    Browne, R.
    Patel, A.
    Stewart, A.
    Tookman, L.
    Counsell, N.
    Miller, R.
    Nicum, S.
    Eminowicz, G.
    CLINICAL ONCOLOGY, 2025, 37
  • [38] Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan
    Miyamoto, Satoshi
    Tsukaguchi, Akihiro
    Kuhara, Hanako
    Otsuki, Taiichiro
    Shiroyama, Takayuki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Nishino, Kazumi
    Takeda, Yoshito
    Kijima, Takashi
    Okumura, Meinoshin
    Kumanogoh, Atsushi
    Mori, Masahide
    THORACIC CANCER, 2025, 16 (06)
  • [39] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma:A retrospective,real-world study conducted in China
    Dong-Xu Wang
    Xu Yang
    Jian-Zhen Lin
    Yi Bai
    Jun-Yu Long
    Xiao-Bo Yang
    Samuel Seery
    Hai-Tao Zhao
    World Journal of Gastroenterology, 2020, (30) : 4465 - 4478
  • [40] Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    Shimozato, Naotaka
    Namisaki, Tadashi
    Okano, Akihiro
    Ohana, Masaya
    Kinoshita, Daisuke
    Kawasaki, Toshihiko
    Aihara, Yosuke
    Nakatani, Toshiya
    Kinoshita, Hiroki
    Ann, Tatsuichi
    Saito, Ko
    Yoshida, Motoyuki
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (01) : 173 - 183
12345